Table of contents:
Latest news & events
Featured presentation
In our own words
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Analyst coverage
Stock info
Quote & chart
History & investment calculator
Governance
Management
Board of directors
Governance documents
Committee composition
Resources
Investor contact
Online investor kit
FAQs
RSS feeds
MENU
Investor Relations
Latest
June 13, 2018
Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing
READ MORE
NYSE: NVTA
8.08
+
0.07
+
0.87%
Volume:
3,305,076
20 minute delay
June 22, 2018
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Analyst coverage
Stock info
Quote & chart
History & investment calculator
Governance
Management
Board of directors
Governance documents
Committee composition
Resources
Investor contact
Online investor kit
FAQs
RSS feeds
INVITAE HOME
Latest
June 13, 2018
Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing
READ MORE
NYSE: NVTA
8.08
+
0.07
+
0.87%
Volume:
3,305,076
20m delay
June 22, 2018
Latest news & events
Feature presentation
Download PDF
Events
In our own words
Thumb
Download
Invitae’s mission
What sets us apart
How we’ll do it
Impact on patients
Investor Toolkit
Email Alerts
Sign up to receive Invitae financial information by email.
Email Address:
*
I'D LIKE TO RECEIVE EMAILS ABOUT:
*
Press Release
SEC Filing
Presentation
Event
End of Day Stock Quote
Enter the code shown above.
Investor Contact
1400 16th St.
San Francisco, CA, 94103
Email:
ir@invitae.com
Privacy
|
Terms
|
Licensing
|
Contact
© Invitae Corporation. All rights reserved.
Powered By Q4 Inc.
5.9.0.2